From Shenzhen to the world.
Shenzhen Excellent Technology Co., Ltd. established. Singular focus on personalised skeletal repair.
First patient-matched cranial implants delivered. Early clinical collaborations with FMMU and Southern Medical University.
Begins systematic participation in shaping national guidance for 3D-printed medical devices.
Clinical dataset grows 10x. Complication rate plateaus at < 2%, validating the technical hypothesis at scale.
Provincial recognition of the core technology's contribution to advanced medical device manufacturing.
Comprehensive patent strategy covering materials, structure, manufacturing, and clinical workflow.
Two additional platforms enter the in-vivo / pre-clinical phase. Excellent MedTech now operates three integrated R&D engines.
Quality system certified for Class III device production. Foundation for international regulatory submissions.
国械注准 20263130176 — the first Class III PSI cranial implant validated by a large-cohort prospective clinical study.
CE-MDR in progress, FDA 510(k) scoping, MDSAP programme in motion. MEDICA 2026 debut.
60+ IP rights. A defensible moat.
We have built a comprehensive IP portfolio covering materials science, structural design, manufacturing processes, and clinical workflow. The result is a defensible competitive position in patient-matched implants.
Recognised by the institutions that set the standard.
Guangdong Science & Technology Invention Award
Second Prize — for core technical innovation in patient-matched additive manufacturing.
10 National Guiding Principles
Author / co-author of ten national-level guidelines shaping 3D-printed medical device practice in China.
50+ Clinical Partner Sites
Including FMMU, Southern Medical University, Shenzhen Second People's Hospital, Beijing Tiantan, Huashan, Xuanwu.